Soper Stanley E

Avg. Two Year Performance

(11%) Avg. Purchase Return
(5%) Compound
8% Avg. Sale Return
4% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(13%)12%11%15%(11%)
Purchase Success Rate0 of 41 of 41 of 41 of 40 of 4
Average Sale Return10%4%< 1%(3%)8%
Sale Success Rate5 of 104 of 105 of 105 of 105 of 10

Nutraceutical International...

Drugs » Drug Related Products

Senior Vice President and CLO:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--